The Drawdown

← Back to Insights

The Topline

Duration Insights

GPU financing has entered the institutional ABS market and we’re watching closely.

CoreWeave’s $8.5 billion investment-grade facility that closed in March is the moment this got real. It’s the first time GPU-backed lending earned institutional-grade ratings: A3 from Moody’s, A-low from DBRS. That pulls the whole category out of venture debt (high-yield, sponsor-backed, equity kickers) and into infrastructure debt (investment-grade, collateral-backed, fixed coupons).

What we find interesting is the number of question marks here versus more traditional ABS markets like mortgages and autos. These GPU deals have one key input with huge uncertainty: salvage value of the collateral. Will these chips still be useful in 1, 5, or 10 years given the pace of improvement in each new wave of chips hitting the market? Lenders are thinking about this by:

With all that said, these deals can be structured to earn a healthy credit rating and access cheaper debt markets, and demand for these chips has only increased since the advent of AI.

AI infrastructure will absorb more than $3.5 trillion in cumulative investment through 2030. That money has to come from somewhere, and equity can’t carry it alone. Debt markets are absorbing the load. Understanding how that debt is being priced, collateralized, and managed is not optional anymore.

Duration is working on a few transactions in this market and we welcome conversations across originators, off-takers, and lenders as this asset class continues to heat up.

— Kevin Houston, Duration Growth Advisors

Recent Debt Financings

• Spellbook · $40M · RBCx

  AI-powered contract copilot used by 4,000 law firms across 80 countries; debt financing to support strategic acquisitions in the consolidating legal AI market. (Source)

• Nitra · $20M · Avenue Capital

  AI-native operating system for healthcare practices surpassing $1 billion in processing volume; debt facility is part of a $187M financing to scale platform adoption. (Source)

• Qover · $12M · CIBC Innovation Banking

  Brussels-based embedded insurance orchestration platform; growth capital facility brings total funding past $100 million. (Source)

• Gradient AI · Undisclosed · CIBC Innovation Banking

  AI-powered insurance underwriting platform based in Boston; growth capital to scale claim prediction and pricing solutions. (Source)

• WellSaid Labs · Undisclosed · Multiplier Capital

  Enterprise voice AI platform serving Microsoft, T-Mobile, and Progressive with 120+ natural-sounding AI voices; venture debt to scale commercial operations. (Source)

• Pulmonx · $60M · Perceptive Advisors

  Medical technology company developing minimally invasive treatments for severe emphysema; $40M drawn at close with $20M available through 2027. (Source)

• Sage Health · $50M · Trinity Capital

  Full-risk primary care and wellness provider serving Medicare-eligible seniors; capital to scale physical center expansion across new markets. (Source)

• Hyperfine · $40M · Horizon Technology Finance

  Portable AI-powered MRI brain imaging system; $15M funded at close with another $25M available through 2027. (Source)

• Monteris Medical · $35M · Trinity Capital

  Neurosurgical laser platform for minimally invasive brain procedures; facility retires prior Madryn credit facility with improved terms and longer tenor. (Source)

• Neuros Medical · $35M · Trinity Capital

  Non-opioid neuromodulation therapy for post-amputation pain; capital to scale commercialization following federal regulatory approval. (Source)

• Cinclus Pharma · €28M · Claret Capital Partners

  Swedish biotech developing next-generation gastric acid treatments; four milestone-based tranches combining secured term loans with convertibles and warrants; €8M drawn at close. (Source)

• Turn Therapeutics · $25M · Avenue Capital

  Gene therapy company focused on dermatological conditions; $7M funded at close with up to $18M available on clinical and corporate milestones. (Source)

• Emboline · $20M · Trinity Capital

  Embolic protection catheter for structural heart interventions; capital to support commercialization of the Emboliner system for minimizing stroke risk during TAVR procedures. (Source)

• Wellster Healthtech Group · €10M · Claret Capital Partners

  German digital healthcare company offering telemedicine and online pharmacy services; follow-on growth investment expanding existing facility to €10M total, supporting international expansion including launch of GoLighter obesity platform in Sweden. (Source)

• Persimmon.Life · Undisclosed · Decathlon Capital

  At-home medical aesthetics and wellness provider with 500+ registered nurses delivering personalized treatments; revenue-based financing to fund growth initiatives. (Source)

Platform & Capital Moves

• Horizon Technology Finance & Monroe Capital

  Received shareholder approval to merge with 83% and 88% support respectively, combining two venture lending BDCs into a single platform expected to close April 14 with Horizon as the surviving entity. (Source)

• Brightwood Capital

  Assumed management of two private credit funds (~$300M in commitments) previously managed by Capital Dynamics, expanding its mid-market direct lending platform across senior secured and unitranche strategies. (Source)

• 17Capital — $7.5B Credit Fund 2 final close

  Set a new record for NAV lending and demonstrated intense institutional demand for fund-level liquidity solutions as private equity exits remain gridlocked. (Source)

• Blue Owl Capital — $2.9B Asset Special Opportunities Fund IX

  Closed at $2.9 billion (exceeding the $2.5 billion target), reflecting institutional demand for diversified, asset-backed opportunistic credit. (Source)

• Atempo Growth — €455M third close on Atempo Growth II

  Backed by Banco Santander, British Business Investments, EIF, and CDP Venture Capital, targeting late-stage European scale-ups with specific focus on Italy. (Source)

• Partners for Growth — A$250M PFG Income Fund first close

  Targeting later-stage Australian technology and fintech companies with flexible growth debt and structured credit. (Source)

• TriplePoint Venture Growth — $75M senior unsecured notes

  Issued 7.50% notes due 2028 in private placement, refinancing a $200M maturity and extending income fee waiver through 2026 to stabilize NAV. (Source)

• Trinity Capital — $100M senior unsecured notes

  Priced 7.875% notes due 2029 with an underwriter option for an additional $15M, earmarking proceeds to repay existing bank debt and potentially redeem its 7.00% 2025 notes. (Source)

• Hambro Perks — £100M Growth Debt Fund first close

  Co-anchor commitment from British Business Investments, targeting UK and European B2B SaaS and patented-hardware scale-ups with venture debt facilities. (Source)

• Horizon Technology Finance & CR Financial Holdings — $100M JV

  With Horizon committing $87.5M to provide growth capital and secured financing to small- and micro-cap public companies. (Source)

• Trinity Capital & Capital Southwest — $100M JV

  $50M each, targeting first-out senior secured debt opportunities in the lower middle market. (Source)

• Apex Group & BlackRock — Private credit partnership

  Strategic partnership for private credit outsourcing directly via the Aladdin Provider Network, enabling asset managers to scale sophisticated lending without operational bloat. (Source)

• CoreWeave — $8.5B investment-grade DDTL

  Led by MUFG, Morgan Stanley, and Blackstone Credit & Insurance, achieving A3 (Moody's) and A-low (DBRS) ratings and establishing GPU-backed debt as an institutional-grade asset class. (Source)

Recommended Reading

On Our Radar

• The Horizon/Monroe Capital merger is expected to close April 14, combining two venture lending BDCs into a single platform — we'll be watching how the combined portfolio is rationalized and whether it triggers further consolidation.

• The Venture Debt Conference returns to the Edison Ballroom in New York on April 16, with 400+ senior professionals expected across the growth-capital ecosystem. We'll be there — if you're attending, come say hello.